+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
FEMALE
ID06007027

Laser Treatment for Genitourinary Syndrome in Breast Cancer Survivors Undergoing Endocrine Therapy A Randomized, Blinded, Placebo-Controlled Study Using Vaginal CO2 Laser

Led by University of Aarhus · Updated on 2024-12-05

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating vaginal CO2 laser therapy for genitourinary syndrome of menopause in breast cancer survivors who are undergoing endocrine therapy. This study involves three parts over three years, including a dose response study with 30 participants, a double-blind randomized controlled trial with 60 participants receiving either active or placebo laser treatment, and a one-year follow-up to assess long-term effects. The study is conducted at departments of obstetrics, gynecology, and oncology in collaboration at regional hospitals and a university hospital. Participants in the active laser group receive intravaginal treatment using the fractional microablative CO2 laser system with specific power and timing settings, while the sham group receives a placebo laser treatment with much lower power settings. The dose response study involves five treatments spaced 4-6 weeks apart, and the randomized trial involves three to five treatments every three weeks. The follow-up year monitors changes after treatment completion. During the study, participants will complete questionnaires and undergo assessments including vaginal fluid pH measurements, vaginal biopsies, and analyses of vaginal and urine microbiomes before and after each treatment. Researchers will measure symptoms such as vaginal dryness, pain, itching, soreness, sexual function, urinary symptoms, and vaginal health. These outcomes are evaluated at baseline and one month after the last treatment. The study includes safety monitoring and lasts until March 2026.

CONDITIONS

Brief Title

Vaginal CO2 Laser Therapy for Genitourinary Syndrome in Breast Cancer Survivors

Research Team

S

Sine Jacobsen, MD

P

Pinar Bor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here